Metformin Pinewood (Metformin Hydrochloride)

Metformin acts primarily by activating AMP‑activated protein kinase (AMPK), which suppresses hepatic glucose production and enhances insulin‑mediated glucose uptake in muscle and fat tissues. This dual action results in lower circulating glucose concentrations.

The dosage of Metformin Pinewood is individualized. A qualified prescriber determines the appropriate strength, frequency, and titration schedule based on the patient’s clinical condition, renal function, and response to therapy.

Safety data in pregnancy and lactation are limited. Metformin should be used during pregnancy or breastfeeding only when the potential benefit justifies the possible risk to the fetus or infant, and always under medical supervision.

To order, submit an enquiry on the Metformin Pinewood product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Compared with sulfonylureas, Metformin does not cause insulin‑induced weight gain and has a lower risk of hypoglycemia. Unlike SGLT2 inhibitors, it does not increase urinary glucose excretion but is effective as a first‑line agent for most patients with type 2 diabetes.

Store Metformin Pinewood at ambient temperature, preferably below 25 °C. Keep the tablets in their original container, protect them from moisture and direct sunlight, and ensure they are out of reach of children.

Metformin Pinewood is taken orally, usually with meals to reduce gastrointestinal discomfort. The tablets should be swallowed whole with a full glass of water and not crushed or chewed unless specifically instructed by a healthcare professional.

The most serious adverse events include lactic acidosis, a rare but potentially fatal condition, and severe hypoglycemia when combined with insulin or sulfonylureas. Long‑term therapy may also lead to vitamin B12 deficiency, which should be monitored periodically.

Metformin Pinewood is contraindicated in patients with severe renal impairment (eGFR < 30 mL/min/1.73 m²), acute or chronic metabolic acidosis, significant hepatic disease, or those experiencing acute heart failure. It should also be avoided in individuals with known hypersensitivity to metformin.